Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,728 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ghrelin mimics fasting to enhance human hedonic, orbitofrontal cortex, and hippocampal responses to food.
Goldstone AP, Prechtl CG, Scholtz S, Miras AD, Chhina N, Durighel G, Deliran SS, Beckmann C, Ghatei MA, Ashby DR, Waldman AD, Gaylinn BD, Thorner MO, Frost GS, Bloom SR, Bell JD. Goldstone AP, et al. Among authors: bloom sr. Am J Clin Nutr. 2014 Jun;99(6):1319-30. doi: 10.3945/ajcn.113.075291. Epub 2014 Apr 23. Am J Clin Nutr. 2014. PMID: 24760977 Free PMC article. Clinical Trial.
Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution.
Goldstone AP, Thomas EL, Brynes AE, Bell JD, Frost G, Saeed N, Hajnal JV, Howard JK, Holland A, Bloom SR. Goldstone AP, et al. Among authors: bloom sr. J Clin Endocrinol Metab. 2001 Sep;86(9):4330-8. doi: 10.1210/jcem.86.9.7814. J Clin Endocrinol Metab. 2001. PMID: 11549670 Clinical Trial.
Fasting and postprandial hyperghrelinemia in Prader-Willi syndrome is partially explained by hypoinsulinemia, and is not due to peptide YY3-36 deficiency or seen in hypothalamic obesity due to craniopharyngioma.
Goldstone AP, Patterson M, Kalingag N, Ghatei MA, Brynes AE, Bloom SR, Grossman AB, Korbonits M. Goldstone AP, et al. Among authors: bloom sr. J Clin Endocrinol Metab. 2005 May;90(5):2681-90. doi: 10.1210/jc.2003-032209. Epub 2005 Feb 1. J Clin Endocrinol Metab. 2005. PMID: 15687345
Repeated ICV administration of oxyntomodulin causes a greater reduction in body weight gain than in pair-fed rats.
Dakin CL, Small CJ, Park AJ, Seth A, Ghatei MA, Bloom SR. Dakin CL, et al. Among authors: bloom sr. Am J Physiol Endocrinol Metab. 2002 Dec;283(6):E1173-7. doi: 10.1152/ajpendo.00233.2002. Epub 2002 Jul 30. Am J Physiol Endocrinol Metab. 2002. PMID: 12388165 Free article.
We reported that intracerebroventricular (ICV) and intranuclear administration of OXM caused an inhibition of food intake in rats (Dakin CL, Gunn I, Small CJ, Edwards CM, Hay DL, Smith DM, Ghatei MA, and Bloom SR. Endocrinology 142: 4244-4250, 2001). In this study, …
We reported that intracerebroventricular (ICV) and intranuclear administration of OXM caused an inhibition of food intake in rats (Dakin CL, …
Inhibition of food intake in obese subjects by peptide YY3-36.
Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR. Batterham RL, et al. Among authors: bloom sr. N Engl J Med. 2003 Sep 4;349(10):941-8. doi: 10.1056/NEJMoa030204. N Engl J Med. 2003. PMID: 12954742 Free article. Clinical Trial.
1,728 results